id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
bam-8231	Sharifi, Zahra; Yazdi, Majid Jalal; Eshraghi, Ali; Vakili, Vida; Ramezani, Javad	Clinical outcomes and complications of treatment with supraflex stent in patients with coronary artery disease: One-year follow-up	2019	7	.pdf	application/pdf	4357	233	57	Of course, the efficacy and relative efficacy of biodegradable polymer stents have not yet been fully elucidated and have not had enough power studies to determine their differences in deaths, cardiac deaths, myocardial infarction (MI) and ST and the level of target vessel revascularization (TVR). A new generation of durable polymer stents, the Durable polymer everolimus-eluting stent, has been shown to reduce ST cases when compared to the paclitaxel-eluting stent.27,28 Despite the fact that the proper performance of the new generation of durable polymer stents has been identified, but the results of several clinical trials such as LEADERS,24 ISAR- TEST3,29 and ISAR-TEST4,30 all indicated a significant improvement in the outcomes of treatment using Biodegradable-Polymer Drug-Eluting Stent that used Biomatrix Flex and ISAR stents, respectively.	cache/bam-8231.pdf	txt/bam-8231.txt